NuVision Biotherapies
PrivateLast Round
Early Funding
Feb 5, 2026
Total Funding Raised
$7.81M
Company Overview
NuVision Biotherapies is a biotechnology company that develops and manufactures ophthalmic therapy products designed to offer surgeons new therapies for ocular care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Freemium
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NuVision Biotherapies Comps
Public and private peers based on sector, stage, and business model.
NuVision Biotherapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Feb 5, 2026 | ||||
| VC Round | Mar 8, 2023 | ||||
| VC Round | Jul 15, 2021 | ||||
| Seed | Feb 8, 2018 | ||||
| Seed | Jul 28, 2015 |
Key People
Founding team and executive leadership
NuVision Biotherapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pioneer Group | VC Round, Early Funding |
| Mercia Ventures | Early Funding |
| MEIF Proof of Concept & Early Stage Fund | VC Round |
| Midlands Engine Investment Fund | VC Round |
| Midlands Engine Investment Fund II | Early Funding |
| Mercia Ventures | VC Round |
| The University of Nottingham | Seed, VC Round, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
Raised $6.5M in early funding.
- Jan 31, 2025
Launched a new clinical product despite manufacturing challenges.
NuVision Biotherapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NuVision Biotherapies's valuation, stock price, and market status.
